| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.082 | 0.09 |